Cystic Fibrosis Foundation Therapeutics   Report issue

Founded: Bethesda MD United States (2000)

Organization Overview

First Clinical Trial
2000
NCT00271310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Cystic Fibrosis Foundation Therapeutics